Duo of directors appointed at Dyax
This article was originally published in Scrip
Executive Summary
Dyax Corp, a developer of novel biotherapeutics for unmet medical needs, has appointed Dr Ron Cohen and Paolo Pucci to its board of directors. In addition, Dr Cohen will serve on the compensation committee and Mr Pucci on the audit committee. Dr Cohen is the founder, president and CEO of Acorda Therapeutics, and Mr Pucci is CEO and a director of ArQule.